Integral Derivatives’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Integral Derivatives’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,620	Closed	-$329K	–	1114
2017 Q4	$346K	Sell	2,620 -5,915	-69%	-$695K	0.01%	832
2017 Q3	$866K	Buy	+8,535	New	+$914K	0.02%	543
2016 Q3	–	Sell	-4,858	Closed	-$445K	–	1203
2016 Q2	$445K	Buy	+4,858	New	+$409K	0.01%	633

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Integral Derivatives's GWPH Position: Q1 2018 in Review

Integral Derivatives sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 2,620 shares — an estimated $329K sold.

Integral Derivatives first reported a position in GWPH in Q2 2016 and held it in 3 quarters. The position peaked at $866K in Q3 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

Integral Derivatives reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 2,620 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $329K.
Integral Derivatives first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 3 quarters.
Integral Derivatives's GW Pharmaceuticals Plc American Depositary Shares position peaked at $866K in Q3 2017.
191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.